Elżbieta Rypulak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elżbieta Rypulak has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anna Greguła
Independent Public Health Care Center in Łęczna, Krasnystawska 52 street, 21-010 Łęczna, Poland
1 shared publication - Bartosz Mazur
Stefan Kardynał Wyszyński Province Specialist Hospital in Lublin, Kraśnicka 100 avenue, 20-718 Lublin, Poland
1 shared publication - Dawid Mika
1st Military Clinical Hospital with SPZOZ Polyclinic in Lublin, Racławickie 23 avenue, 20-049 Lublin, Poland
1 shared publication - Iwona Welian-Polus
Medical University of Lublin
1 shared publication - Kamila Turek
Medical University of Lublin, Racławickie 1 avenue, 20-059 Lublin, Poland
1 shared publication - Karol Stachyrak
Independent Public Health Care Center in Łęczna Krasnystawska 52 street, 21-010 Łęczna, Poland
1 shared publication
Latest Publications
- Open Access
- 14 May 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 68, 50187
Aggravation of Cardiovascular and Respiratory Decline in Advanced Duchenne Muscular Dystrophy Complicated by Dilated Cardiomyopathy – Case Study and Review of Literature
Introduction: Duchenne muscular dystrophy is a genetic X-linked recessive disorder. This condition is characterized by progressive loss of muscle tissue. Thus, it results in deterioration and inability to perform basic motor skills such as independent movement or breathing. Due to progressive muscle weakness, patients with advanced stages of DMD require mechanical ventilation, feeding, and rehabilitation. Furthermore, alterations in cardiac muscle lead to cardiomyopathy. Despite advanced supportive treatment, DMD is a fatal disease. Purpose: The aim of the paper is to present, using a case study description, the current standards of treatment for patients with Duchenne muscular dystrophy as well as the current state of knowledge and new discoveries regarding this medical condition. Material and methods The patient's medical records were analyzed and available literature in PubMed was reviewed to write this article using the keywords: „Duchenne muscular dystrophy”; „cardiomyopathy”; „mechanical ventilation”; „gene therapy”; Conclusions Early detection of respiratory and circulatory insufficiency improves the patient's quality of life. Many patients with an advanced stage of Duchenne muscular dystrophy need specialized treatment, for example, in the intensive care unit. Therefore there is an urgent need for new treatment methods, such as gene therapies, which can slow down or break the course of the disease. New discoveries and the implementation of new treatment standards can enhance the quality of life for patients and extend their lifespans.
- 14 May 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 68, 50187
Open AccessAggravation of Cardiovascular and Respiratory Decline in Advanced Duchenne Muscular Dystrophy Complicated by Dilated Cardiomyopathy – Case Study and Review of Literature
Introduction: Duchenne muscular dystrophy is a genetic X-linked recessive disorder. This condition is characterized by progressive loss of muscle tissue. Thus, it results in deterioration and inability to perform basic motor skills such as independent movement or breathing. Due to progressive muscle weakness, patients with advanced stages of DMD require mechanical ventilation, feeding, and rehabilitation. Furthermore, alterations in cardiac muscle lead to cardiomyopathy. Despite advanced supportive treatment, DMD is a fatal disease. Purpose: The aim of the paper is to present, using a case study description, the current standards of treatment for patients with Duchenne muscular dystrophy as well as the current state of knowledge and new discoveries regarding this medical condition. Material and methods The patient's medical records were analyzed and available literature in PubMed was reviewed to write this article using the keywords: „Duchenne muscular dystrophy”; „cardiomyopathy”; „mechanical ventilation”; „gene therapy”; Conclusions Early detection of respiratory and circulatory insufficiency improves the patient's quality of life. Many patients with an advanced stage of Duchenne muscular dystrophy need specialized treatment, for example, in the intensive care unit. Therefore there is an urgent need for new treatment methods, such as gene therapies, which can slow down or break the course of the disease. New discoveries and the implementation of new treatment standards can enhance the quality of life for patients and extend their lifespans.
- Open Access
- 27 June 2023
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 17 (3) , 212-214
Urinary tract infection as cause of a septic miscarriage and disseminated intravascular coagulation – case report and literature review
Urinary tract infection (UTI) is one of the most common bacterial infections which affectis 150 million people worldwide annually. Pregnant women are particularly vulnerable to UTIs. Untreated asymptomatic bacteriuria in pregnancy can develop into an acute state, leading to serious complications,...
- 27 June 2023
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 17 (3) , 212-214
Open AccessUrinary tract infection as cause of a septic miscarriage and disseminated intravascular coagulation – case report and literature review
Urinary tract infection (UTI) is one of the most common bacterial infections which affectis 150 million people worldwide annually. Pregnant women are particularly vulnerable to UTIs. Untreated asymptomatic bacteriuria in pregnancy can develop into an acute state, leading to serious complications,...